Literature DB >> 15538400

Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia.

B Gustafsson, S Angelini, B Sander, B Christensson, K Hemminki, R Kumar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15538400     DOI: 10.1038/sj.leu.2403589

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways.

Authors:  Neerav Shukla; Nabahet Ameur; Ismail Yilmaz; Khedoudja Nafa; Chyau-Yueh Lau; Angela Marchetti; Laetitia Borsu; Frederic G Barr; Marc Ladanyi
Journal:  Clin Cancer Res       Date:  2011-12-05       Impact factor: 12.531

Review 2.  Selective Raf inhibition in cancer therapy.

Authors:  Vladimir Khazak; Igor Astsaturov; Ilya G Serebriiskii; Erica A Golemis
Journal:  Expert Opin Ther Targets       Date:  2007-12       Impact factor: 6.902

3.  Initial testing (stage 1) of the multi-targeted kinase inhibitor sorafenib by the pediatric preclinical testing program.

Authors:  Stephen T Keir; John M Maris; Richard Lock; E Anders Kolb; Richard Gorlick; Hernan Carol; Christopher L Morton; C Patrick Reynolds; Min H Kang; Amy Watkins; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2010-12-01       Impact factor: 3.167

4.  BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS.

Authors:  Liping Zhang; Rajesh R Singh; Keyur P Patel; Francesco Stingo; Mark Routbort; M James You; Roberto N Miranda; Guillermo Garcia-Manero; Hagop M Kantarjian; L Jeffrey Medeiros; Rajyalakshmi Luthra; Joseph D Khoury
Journal:  Am J Hematol       Date:  2014-02-10       Impact factor: 10.047

5.  BRAF mutations in hairy-cell leukemia.

Authors:  Enrico Tiacci; Vladimir Trifonov; Gianluca Schiavoni; Antony Holmes; Wolfgang Kern; Maria Paola Martelli; Alessandra Pucciarini; Barbara Bigerna; Roberta Pacini; Victoria A Wells; Paolo Sportoletti; Valentina Pettirossi; Roberta Mannucci; Oliver Elliott; Arcangelo Liso; Achille Ambrosetti; Alessandro Pulsoni; Francesco Forconi; Livio Trentin; Gianpietro Semenzato; Giorgio Inghirami; Monia Capponi; Francesco Di Raimondo; Caterina Patti; Luca Arcaini; Pellegrino Musto; Stefano Pileri; Claudia Haferlach; Susanne Schnittger; Giovanni Pizzolo; Robin Foà; Laurent Farinelli; Torsten Haferlach; Laura Pasqualucci; Raul Rabadan; Brunangelo Falini
Journal:  N Engl J Med       Date:  2011-06-11       Impact factor: 91.245

6.  Initial testing (stage 1) of AZD6244 (ARRY-142886) by the Pediatric Preclinical Testing Program.

Authors:  E Anders Kolb; Richard Gorlick; Peter J Houghton; Christopher L Morton; Geoffrey Neale; Stephen T Keir; Hernan Carol; Richard Lock; Doris Phelps; Min H Kang; C Patrick Reynolds; John M Maris; Catherine Billups; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2010-10       Impact factor: 3.167

7.  Mutations in the c-Kit gene disrupt mitogen-activated protein kinase signaling during tumor development in adenoid cystic carcinoma of the salivary glands.

Authors:  Osamu Tetsu; Janyaporn Phuchareon; Annie Chou; Darren P Cox; David W Eisele; Richard C K Jordan
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

Review 8.  The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.

Authors:  J Eswaran; P Sinclair; O Heidenreich; J Irving; L J Russell; A Hall; D P Calado; C J Harrison; J Vormoor
Journal:  Leukemia       Date:  2015-05-06       Impact factor: 11.528

9.  Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720.

Authors:  Tamihiro Kamata; David Dankort; Jing Kang; Susan Giblett; Catrin A Pritchard; Martin McMahon; Andrew D Leavitt
Journal:  Mol Cancer Res       Date:  2013-10-23       Impact factor: 5.852

10.  Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.

Authors:  Nidhi Aggarwal; Steven H Swerdlow; Lindsey M Kelly; Jennifer B Ogilvie; Mariana N Nikiforova; Malini Sathanoori; Yuri E Nikiforov
Journal:  Mod Pathol       Date:  2012-05-11       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.